Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Venetian-1 Acquisition Corp. | President and COO, Director | Common Stock | 2.68M | $10.7M | $4.00 | Nov 1, 2024 | By TPAV, LLC |
Venetian-1 Acquisition Corp. | President and COO, Director | Stock Option (Right to Buy) | 1.26M | Nov 1, 2024 | Direct | ||
Traws Pharma, Inc. | Chief Operating Officer, Director | Pre-Funded Warrant (right to buy) | 96.3K | Dec 29, 2024 | By TPAV, LLC | ||
Traws Pharma, Inc. | Chief Operating Officer, Director | Series A Warrant (right to buy) | 96.3K | Dec 29, 2024 | By TPAV, LLC | ||
Traws Pharma, Inc. | Chief Operating Officer, Director | Stock Option (right to purchase) | 22.4K | Oct 12, 2025 | Direct | ||
Venetian-1 Acquisition Corp. | President and COO, Director | Simple Agreement for Future Equity | 0 | Nov 1, 2024 | By TPAV, LLC |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TRAW | Traws Pharma, Inc. | Oct 12, 2025 | 1 | $0 | 4 | Oct 15, 2025 | Chief Operating Officer, Director |
TRAW | Traws Pharma, Inc. | Dec 29, 2024 | 2 | $0 | 4 | Jan 27, 2025 | Chief Operating Officer, Director, 10%+ Owner |
NONE | Lomond Therapeutics Holdings, Inc. | Nov 1, 2024 | 6 | $10M | 4 | Nov 5, 2024 | President and COO, Director |
NONE | Lomond Therapeutics Holdings, Inc. | Nov 1, 2024 | 0 | $0 | 3 | Nov 5, 2024 | President and COO, Director |
TRAW | Traws Pharma, Inc. | Apr 1, 2024 | 1 | $0 | 4/A | Aug 7, 2024 | Chief Operating Officer, Director |
TRAW | Onconova Therapeutics, Inc. | Apr 1, 2024 | 8 | $0 | 4 | Apr 3, 2024 | Chief Operating Officer, Director |
TRAW | Onconova Therapeutics, Inc. | Apr 1, 2024 | 0 | $0 | 3 | Apr 3, 2024 | Chief Operating Officer, Director |